EZH2 Supports Osteoclast Differentiation and Bone Resorption Via Epigenetic and Cytoplasmic TargetsJuraj Adamik, Deborah L. Galson|Journal of Bone and Mineral Research|2019Cited by 42
Abstract 2485: A combined mregDC and Treg signature associates with antitumor efficacy of CCR4 antagonist tivumecirnon FLX475Adam Grant, George E. Katibah, Jingtao Qiu et al.|Cancer Research|2024Cited by 1